|
InvivoGen
a549ace2 tmprss2 cells A549ace2 Tmprss2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/A549-hACE2-TMPRSS2+Cells/pm42735890-50-17-19 Average 99 stars, based on 1 article reviews
a549ace2 tmprss2 cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
vero e6 tmprss2 ![]() Vero E6 Tmprss2, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/Vero/pmc13651819-173-0-2 Average 99 stars, based on 1 article reviews
vero e6 tmprss2 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
ATCC
cell models hek293t hace2 bei resources nr 52511 vero tmprss2 nibsc 100978 vero e6 atcc crl 1586 virus sars cov 2 b 1 351 andy pekosz ![]() Cell Models Hek293t Hace2 Bei Resources Nr 52511 Vero Tmprss2 Nibsc 100978 Vero E6 Atcc Crl 1586 Virus Sars Cov 2 B 1 351 Andy Pekosz, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/VERO+C1008/pm42864420-413-31-43 Average 99 stars, based on 1 article reviews
cell models hek293t hace2 bei resources nr 52511 vero tmprss2 nibsc 100978 vero e6 atcc crl 1586 virus sars cov 2 b 1 351 andy pekosz - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Addgene inc
transmembrane serine protease 2 ![]() Transmembrane Serine Protease 2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/TMPRSS2+(Plasmid+%2353887)/pm42792860-253-8-15 Average 94 stars, based on 1 article reviews
transmembrane serine protease 2 - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
|
InvivoGen
a549-hace2-tmprss2 cells ![]() A549 Hace2 Tmprss2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/A549-hACE2-TMPRSS2+Cells/custom%40a549-hace2tpsa%4010%2E64898%2F2026%2E08%2E14%2E744970 Average 99 stars, based on 1 article reviews
a549-hace2-tmprss2 cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
InvivoGen
tmprss2 ![]() Tmprss2, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/A549-Dual+hACE2-TMPRSS2+Cells/pm42160828-220-9-11 Average 99 stars, based on 1 article reviews
tmprss2 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
InvivoGen
a549-dual hace2-tmprss2 cells ![]() A549 Dual Hace2 Tmprss2 Cells, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/A549-Dual+hACE2-TMPRSS2+Cells/custom%40a549d-cov2r%4042160828 Average 99 stars, based on 1 article reviews
a549-dual hace2-tmprss2 cells - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
Takeda
tmprss2 ![]() Tmprss2, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/diacylglycerol+exhibit+kinase+knockout+lithium+mice+sensitive+%CE%B2/pm42248900-177-4-10 Average 86 stars, based on 1 article reviews
tmprss2 - by Bioz Stars,
2026-11
86/100 stars
|
Buy from Supplier |
|
InvivoGen
human ace2 expressing a549 ![]() Human Ace2 Expressing A549, supplied by InvivoGen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/A549-hACE2-TMPRSS2+Cells/pmc13303877-8-0-4 Average 99 stars, based on 1 article reviews
human ace2 expressing a549 - by Bioz Stars,
2026-11
99/100 stars
|
Buy from Supplier |
|
OriGene
human tmprss2 targeting shrna sequences ![]() Human Tmprss2 Targeting Shrna Sequences, supplied by OriGene, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/tmprss2/TMPRSS2+Human+shRNA+Plasmid+Kit/pm42156913-285-22-28 Average 94 stars, based on 1 article reviews
human tmprss2 targeting shrna sequences - by Bioz Stars,
2026-11
94/100 stars
|
Buy from Supplier |
Journal: iScience
Article Title: Gapmers targeting conserved SARS-CoV-2 single-stranded regions reduce viral load and reshape inflammatory macrophage responses
doi: 10.1016/j.isci.2026.117639
Figure Lengend Snippet:
Article Snippet:
Techniques: Virus, Variant Assay, Recombinant, Reverse Transcription, Diagnostic Assay, Luminex, Ligation, Multiplex Assay, Generated, Software
Journal: EMBO Reports
Article Title: TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions
doi: 10.1038/s44319-026-00797-2
Figure Lengend Snippet: ( A ) Infectivity of CoV-2-S pseudotyped lentiviruses was determined in ACE2- and TMPRSS2-WT (TM2-WT), TMPRSS2-WT-mCherry- (TM2-WT-Cherry)-, TMPRSS2-dCT-mCherry- (TM2-dCT-Cherry)-, TMPRSS2-S441A-mCherry- (TM2-S441A-Cherry)-, and/or TMPRSS2-WT-Wasabi- (TM2-WT-Wasabi)-expressing 293T cells (left and middle, the quantified results from a representative experiment in the two experiments independently conducted are expressed as mean ± SEM, n = 6). Infectivity of CoV-2-S pseudotyped lentiviruses was determined in ACE2- and TM2-WT-Cherry (with indicated ratio of plasmids) expressing 293 T cells (right, the quantified results are expressed as mean ± SEM of three separate experiments, n = 3). Representative data from three independent experiments are shown. ( B ) Immunoblotting analysis of cell lysate from 293 T cells expressing CoV-2-S (left) or HIV-1 Env (right) and TM2-WT-mCherry (TM2-WT) or TM2-S441A-mCherry (TM2-S441A). The ratio of CoV-2-S2 or gp160 to beta-actin was calculated based on band density (the quantified results are expressed as mean ± SEM of three separate experiments, n = 3). ( C ) Fluorescence microscopy analysis of A549-ACE2 and A549-ACE2-TMPRSS2-mCherry- (TM2)-expressing cells. ( D ) Infectivity of SARS-CoV-2 spike protein pseudotyped lentiviruses in ACE2- or ACE2- and TM2-expressing A549 cells (the quantified results from a representative experiment in the two experiments independently conducted are expressed as mean ± SEM, n = 4). ( E ) q-PCR analysis for TMPRSS2 (TM2) mRNA in indicated cell lines (A549-ACE2-TM2: A549-ACE2 cells stably expressing TM2; 293T-TM2: 293T cells transiently expressing TM2) (the quantified results from a representative experiment in the two experiments independently conducted are expressed as mean ± SEM, n = 3). ( F ) q-PCR analysis for TM2 mRNA in original Caco-2 (Caco-2 WT) and TM2 knockdown Caco-2 (Caco-2 TM2-KD) cells (the quantified results from a representative experiment in the two experiments independently conducted are expressed as mean ± SEM, n = 3). Scale bars indicate 50 μm. The results of Student’s t tests are shown above the bars.
Article Snippet:
Techniques: Infection, Expressing, Western Blot, Fluorescence, Microscopy, Stable Transfection, Knockdown
Journal: EMBO Reports
Article Title: TMPRSS2-induced Golgi disruption restricts the incorporation of virus envelope glycoproteins into virions
doi: 10.1038/s44319-026-00797-2
Figure Lengend Snippet: ( A ) Experimental scheme and luciferase activity for the infectivity of SARS-CoV-2-Spike (CoV-2-S) or vesicular stomatitis virus G protein (VSV-G) pseudotyped lentiviruses produced in CD4-mCherry- (Control)-, TMPRSS2-mCherry- (TM2-WT)-, TMPRSS2-dCT-mCherry- (TM2-dCT)-, or TMPRSS2-S441A-mCherry-(TM2-S441A)-expressing 293T cells. The infectivity of pseudotyped lentiviruses (3 ng/well) normalized with p24 amount (left in panels, the quantified results are expressed as mean ± SEM of three separate experiments, n = 3) was determined in ACE2- and TM2-expressing 293T cells (right in panels, the quantified results from a representative experiment in the three experiments independently conducted are expressed as mean ± SEM, n = 6 for CoV-2-S, n = 5 for VSV-G). ( B ) Experimental scheme (left) and plaque-formation assay using Vero E6 TMPRSS2 cells to test the infectivity of SARS-CoV-2 produced in A549-ACE2 or A549-ACE2 stably expressing TMPRSS2 (A549-ACE2-TM2) cells (middle, n = 3). A549-ACE2 or A549-ACE2-TM2 cells infected with SARS-CoV-2. After normalization with SARS-CoV-2 nucleocapsid protein (NP, left in panels, the quantified results are expressed as mean ± SEM of four separate experiments, n = 4) amounts, the viruses were used in a plaque-formation assay using Vero E6 TMPRSS2 cells. Plaque-forming unit (pfu) per 80 pg of NP is shown (right, the quantified results from a representative experiment in the three experiments independently conducted are expressed as mean ± SEM, n = 6). ( C ) Experimental scheme (top) and luciferase activity for the infectivity of CoV-2-S pseudotyped lentiviruses produced in Calu-3 cells. Calu-3 cells transfected with CoV-2-S and lentiviral plasmids were treated with the indicated concentrations of nafamostat. After normalization with p24 amounts (bottom left, the quantified results are expressed as mean ± SEM of five separate experiments, n = 5), the pseudotyped lentiviruses (1.0 pg/well) were used to infect 293T cells expressing ACE2 (293T-ACE2), but not TM2, and the infectivity was determined as luciferase activity (bottom right, the quantified results from a representative experiment in the two experiments independently conducted are expressed as mean ± SEM, n = 5). ( D ) Immunoblotting analysis of CoV-2-S pseudotyped lentiviruses in 293T cells expressing CD4-mCherry- (Control)-, TM2-WT, TM2-dCT, or TM2-S441A. The ratio of CoV-2-S2 to p24 was calculated based on band density (right, the quantified results are expressed as mean ± SEM of three separate experiments, n = 3). The samples were obtained from the same experiment, and the gels and blots were processed in parallel. ( E ) Experimental scheme (left top) and plaque-formation assay of SARS-CoV-2 produced in nafamostat-treated Caco-2 cells (left bottom, n = 3). Caco-2 cells infected with SARS-CoV-2 were treated with the indicated concentrations of nafamostat. After the 96 hr culture, viruses were purified and normalized with SARS-CoV-2 NP amounts (right top, the quantified results are expressed as mean ± SEM of six separate experiments, n = 6), the viruses were used in a plaque-formation assay using Vero E6 TMPRSS2 cells. Plaque-forming unit (pfu) per 25 pg of NP is shown (right bottom, the quantified results from a representative experiment in the three experiments independently conducted are expressed as mean ± SEM, n = 8). ( F ) Experimental scheme (top) and plaque-formation assay (middle) of SARS-CoV-2 produced in Caco-2 cells ( n = 3). Original (WT) and TM2-knockdown (KD) Caco-2 cells were infected with SARS-CoV-2. After the 96 hr culture and normalization with SARS-CoV-2 NP amounts (bottom left, the quantified results are expressed as mean ± SEM of three separate experiments, n = 3), the viruses were used in a plaque-formation assay using Vero E6 TMPRSS2 cells. Plaque-forming unit (pfu) per 100 pg of NP is shown (right bottom, the quantified results from two experiments among the three experiments independently conducted are expressed as mean ± SEM, n = 6). The number in vectors indicates the ratio of plasmid used for transfection. The results of Student’s t tests are shown above the bars. .
Article Snippet:
Techniques: Luciferase, Activity Assay, Infection, Virus, Produced, Control, Expressing, Plaque Formation Assay, Stable Transfection, Transfection, Western Blot, Purification, Knockdown, Plasmid Preparation